Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
- Resource Type
- Article
- Source
- In
Respiratory Investigation September 2019 57(5):466-471 - Subject
- Language
- ISSN
- 2212-5345